Expression of ciliary neurotrophic factor receptor in myasthenia gravis

[1]  E. Wouters,et al.  Inflammatory Cytokines Inhibit Myogenic Differentiation through Activation of Nuclear Factor-␬b , 2022 .

[2]  G. Trinchieri,et al.  Human thymus contains IFN-alpha-producing CD11c(-), myeloid CD11c(+), and mature interdigitating dendritic cells. , 2001, The Journal of clinical investigation.

[3]  A. Vincent,et al.  Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies , 2001, Nature Medicine.

[4]  E. Senba,et al.  Gene Expression of Receptors for IL-6, LIF, and CNTF in Regenerating Skeletal Muscles , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[5]  R. de Waal Malefyt,et al.  Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation. , 2000, International immunology.

[6]  R. Barohn,et al.  Myasthenia gravis , 2000, Neurology.

[7]  G. Yancopoulos,et al.  The ciliary neurotrophic factor and its receptor, CNTFRα , 2000 .

[8]  J. Changeux,et al.  Induction of utrophin gene expression by heregulin in skeletal muscle cells: role of the N-box motif and GA binding protein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[9]  W. Mayo,et al.  Ciliary Neurotrophic Factor is a Regulator of Muscular Strength in Aging , 1999, The Journal of Neuroscience.

[10]  P. Distefano,et al.  Increased Expression of CNTF Receptor α in Denervated Human Skeletal Muscle , 1998 .

[11]  V. Mouly,et al.  Regulation of acetylcholine receptor gene expression in human myasthenia gravis muscles. Evidences for a compensatory mechanism triggered by receptor loss. , 1998, The Journal of clinical investigation.

[12]  A. Gramolini,et al.  Muscle and Neural Isoforms of Agrin Increase Utrophin Expression in Cultured Myotubes via a Transcriptional Regulatory Mechanism* , 1998, The Journal of Biological Chemistry.

[13]  G. Butler-Browne,et al.  Troponin T mRNA and protein isoforms in the human left ventricle: pattern of expression in failing and control hearts. , 1997, Journal of molecular and cellular cardiology.

[14]  S. Heller,et al.  Onset of CNTFRalpha expression and signal transduction during neurogenesis in chick sensory dorsal root ganglia. , 1997, Developmental biology.

[15]  A. Vincent,et al.  Utrophin abundance is reduced at neuromuscular junctions of patients with both inherited and acquired acetylcholine receptor deficiencies. , 1997, Brain : a journal of neurology.

[16]  B. Sakmann,et al.  Induction by agrin of ectopic and functional postsynaptic-like membrane in innervated muscle. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Howard,et al.  Seronegative myasthenia gravis , 1988, Neurology.

[18]  D. Barritault,et al.  Growth factors in skeletal muscle regeneration. , 1996, Cytokine & growth factor reviews.

[19]  H. Sveistrup,et al.  Ciliary neurotrophic factor: regulation of acetylcholinesterase in skeletal muscle and distribution of messenger RNA encoding its receptor in synaptic versus extrasynaptic compartments , 1996, Neuroscience.

[20]  R. Vejsada,et al.  Cardiotrophin-1, a Cytokine Present in Embryonic Muscle, Supports Long-Term Survival of Spinal Motoneurons , 1996, Neuron.

[21]  M. Ruegg,et al.  Substrate-bound agrin induces expression of acetylcholine receptor epsilon-subunit gene in cultured mammalian muscle cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  E. Vinson,et al.  Immunohistochemical localization of ciliary neurotrophic factor receptor alpha expression in the rat nervous system , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[23]  P. Distefano,et al.  Receptor tyrosine kinase specific for the skeletal muscle lineage: Expression in embryonic muscle, at the neuromuscular junction, and after injury , 1995, Neuron.

[24]  S. Berrih-Aknin,et al.  Regulation of acetylcholine receptor alpha subunit variants in human myasthenia gravis. Quantification of steady-state levels of messenger RNA in muscle biopsy using the polymerase chain reaction. , 1994 .

[25]  P. Distefano,et al.  Trophic effect of ciliary neurotrophic factor on denervated skeletal muscle , 1994, Cell.

[26]  S. Fuchs,et al.  Increased gene expression of acetylcholine receptor and myogenic factors in passively transferred experimental autoimmune myasthenia gravis. , 1993, Journal of immunology.

[27]  P. Distefano,et al.  Released form of CNTF receptor alpha component as a soluble mediator of CNTF responses. , 1993, Science.

[28]  J. Merlie,et al.  The 5'-flanking region of the mouse muscle nicotinic acetylcholine receptor beta subunit gene promotes expression in cultured muscle cells and is activated by MRF4, myogenin and myoD. , 1992, Nucleic acids research.

[29]  S. Fuchs,et al.  Changes in the expression of mRNAs for myogenic factors and other muscle‐specific proteins in experimental autoimmune myasthenia gravis , 1992, FEBS letters.

[30]  S. Varon,et al.  Effects of ciliary neuronotrophic factor on rat spinal cord neurons in vitro: survival and expression of choline acetyltransferase and low-affinity nerve growth factor receptors. , 1991, Brain research. Developmental brain research.

[31]  G. Fanger,et al.  Multiple binding sites for myogenic regulatory factors are required for expression of the acetylcholine receptor gamma-subunit gene. , 1991, The Journal of biological chemistry.

[32]  R. Eftimie,et al.  Myogenin and MyoD join a family of skeletal muscle genes regulated by electrical activity. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Bessereau,et al.  Two adjacent MyoD1-binding sites regulate expression of the acetylcholine receptor α-subunit gene , 1990, Nature.

[34]  S. Landis,et al.  The cholinergic neuronal differentiation factor from heart cell conditioned medium is different from the cholinergic factors in sciatic nerve and spinal cord. , 1990, Developmental biology.

[35]  R. Saiki,et al.  A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. , 1988, Nucleic acids research.

[36]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[37]  Bert Sakmann,et al.  Molecular distinction between fetal and adult forms of muscle acetylcholine receptor , 1986, Nature.

[38]  A. Starzinski-Powitz,et al.  Antigenic modulation of human myotube acetylcholine receptor by myasthenic sera. Serum titer determines receptor internalization rate. , 1986, Journal of immunology.

[39]  J. Sanes,et al.  Neural cell adhesion molecule (N-CAM) accumulates in denervated and paralyzed skeletal muscles. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Changeux,et al.  Nicotinic receptor of acetylcholine: structure of an oligomeric integral membrane protein. , 1984, Physiological reviews.

[41]  S. Self,et al.  Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. , 1982, The New England journal of medicine.

[42]  J. Bach,et al.  Le dosage des anticorps anti-récepteurs de l'acétylcholine dans la myasthénie. Etude de 329 sérums. , 1982 .

[43]  M. Raftery,et al.  The nicotinic cholinergic receptor: correlation of molecular structure with functional properties. , 1982, Annual review of biochemistry.

[44]  A. Vincent,et al.  Immunology of acetylcholine receptors in relation to myasthenia gravis. , 1980, Physiological reviews.

[45]  J. Rosai,et al.  Thymic hyperplasia and neoplasia: a review of current concepts. , 1978, Human pathology.

[46]  R. F. Mayer,et al.  An electrophysiological and morphological study of the neuromuscular junction in patients with myasthenia gravis , 1976, Experimental Neurology.

[47]  D. Drachman,et al.  Neuromuscular Junction in Myasthenia Gravis: Decreased Acetylcholine Receptors , 1973, Science.

[48]  A. Engel,et al.  Histometric study of neuromuscular junction ultrastructure , 1972, Neurology.

[49]  R. Schwab,et al.  Myasthenia gravis , 1955, Neurology.

[50]  B. Csillik,et al.  A new modification of the Koelle-Friedenwald method for the histochemical demonstration of cholinesterase activity. , 1965, Acta histochemica.